Highlights Halucenex is a Psychedelic-Assisted Psychotherapy (PAP) company Halucenex focuses on the commercialisation and R&D of novel psychedelic molecules for the treatment of Post Traumatic...
FRA:1X8
LOI Secured With ImpACTIVE To Drive Growth In North America And Europe
▪ ImpACTIVE is a Canadian company focused on CBD-based products that reduce muscle and joint inflammation ▪ Creso has entered into a non-binding LOI for the distribution of...
Distribution Agreement Secured for Innovative Hemp Derived Therapeutic Products in Pakistan, Philippines and Other New Markets
Up to CHF1.71m (AUD2.48m1) minimum order quantity across CannaQix 10, Cannaqix 50 and CannaDOL product lines. Highlights: Creso enters into Distribution Agreement with Route2 Pharm Pvt Ltd in...
Mernova Medicinal Inc. secures licensing and supply agreement with Khalifa Kush Enterprises
Value – up to AUD$10.25m HighlightsKhalifa Kush Enterprises (KKE) is the Canadian arm of Wiz Khalifa’s global cannabis companyDeal is worth up to $10.25m for CresoMernova and KKE will collaborate to...